ICICI Securities' Analyst, Amit Dixit, examines the impact of Russian metal bans on commodity prices, emphasizing short-term fluctuations a...

Amit Dixit analyzes the impact of global iron ore price changes on NMDC in India, addressing the potential pressure on iron ore prices if s...

“I see a roadmap of production cuts in China for at least the next six months.”

Amit Dixit brings with him over 21 years of experience of product and software development, large-scale platform management, technology roa...

Net profit rose to ₹3,469.88 crore for the quarter ended March 31 from ₹2,647.52 crore a year earlier. Fourth-quarter consolidated revenue ...

There is sufficient headroom for steel price hike, says the VP, Edelweiss Securities.

We will be happy to evaluate tuck-in acquisitions in newer segments, says the Blackstone Senior MD.

"There hasn’t been a trade agreement between US and China in 70 years. So, it's a major progress."

Buy NCC Ltd. at a price target of Rs 136.0 and a stop loss at Rs 129 from the entry point.

Buy NCC Ltd. at a price target of Rs 135.0 and a stop loss at Rs 124 from entry point.

Buy NCC Ltd. at a price target of Rs 129.0 and a stop loss at Rs 118 from entry point.

Buy NCC Ltd. at a price target of Rs 132.0 and a stop loss at Rs 117 from entry point.

Buy NCC Ltd. at a price target of Rs 140.0 and a stop loss at Rs 126 from entry point.

Buy NCC Ltd. at a price target of Rs 135.0 and a stop loss at Rs 118 from entry point.

Buy NCC at a price target of Rs 140 and a stop loss at Rs 127 from entry point.

Buy NCC at a price target of Rs 110 and a stop loss at Rs 96 from entry point.

Private equity major Blackstone is selling its stake in Pune-based Emcure Pharmaceuticals to Bain Capital.